A thermostable protein factor acting on in vitro DNA transcription

1971 ◽  
Vol 45 (6) ◽  
pp. 1597-1607 ◽  
Author(s):  
M. Jacquet ◽  
R. Cukier-Kahn ◽  
J. Pla ◽  
F. Gros
Keyword(s):  
Dna Transcription ◽  
Protein Factor ◽  
Thermostable Protein

Co-purification of bone resorbing activity and adenylate cyclase stimulating activity from human tumours associated with the humoral hypercalcaemia of malignancy

1987 ◽  
Vol 114 (1) ◽  
pp. 18-26 ◽  
Author(s):  
Chohei Shigeno ◽  
Itsuo Yamamoto ◽  
Shegiharu Dokoh ◽  
Megumu Hino ◽  
Jun Aoki ◽  
...  
Keyword(s):  
Bone Resorption ◽  
High Performance ◽  
Basic Protein ◽  
Gel Filtration ◽  
Exchange Chromatography ◽  
Protein Factor ◽  
Human Tumours ◽  
Acid Stable ◽  
Bone Resorbing Activity

Abstract. We have partially purified a tumour factor capable of stimulating both bone resorption in vitro and cAMP accumulation in osteoblastic ROS 17/2 cells from three human tumours associated with humoral hypercalcaemia of malignancy. Purification of tumour factor by sequential acid urea extraction, gel filtration and cation-exchange chromatography, reverse-phase high performance liquid chromatography followed by analytical isoelectric focussing provided a basic protein (pI > 9.3) with a molecular weight of approximately 13 000 as a major component of the final preparation which retained both the two bioactivities. Bone resorbing activity and cAMP-increasing activity in purified factor correlated with each other. cAMP-increasing activity of the factor was heat- and acid-stable, but sensitive to alkaline ambient pH. Treatment with trypsin destroyed cAMP-increasing activity of the factor. Synthetic parathyroid hormone (PTH) antagonist, human PTH-(3– 34) completely inhibited the cAMP-increasing activity of the factor. The results suggest that this protein factor, having its effects on both osteoclastic and osteoblastic functions, may be involved in development of enhanced bone resorption in some patients with humoral hypercalcaemia of malignancy.

scholarly journals Prenylation of Saccharomyces cerevisiae Chs4p Affects Chitin Synthase III Activity and Chitin Chain Length

2006 ◽  
Vol 6 (2) ◽  
pp. 328-336 ◽  
Author(s):  
Kariona A. Grabińska ◽  
Paula Magnelli ◽  
Phillips W. Robbins
Keyword(s):  
Saccharomyces Cerevisiae ◽  
Chain Length ◽  
Attachment Site ◽  
Chitin Synthase ◽  
Yeast Cells ◽  
Average Chain Length ◽  
Calcofluor White ◽  
Protein Factor

ABSTRACT Chs4p (Cal2/Csd4/Skt5) was identified as a protein factor physically interacting with Chs3p, the catalytic subunit of chitin synthase III (CSIII), and is indispensable for its enzymatic activity in vivo. Chs4p contains a putative farnesyl attachment site at the C-terminal end (CVIM motif) conserved in Chs4p of Saccharomyces cerevisiae and other fungi. Several previous reports questioned the role of Chs4p prenylation in chitin biosynthesis. In this study we reinvestigated the function of Chs4p prenylation. We provide evidence that Chs4p is farnesylated by showing that purified Chs4p is recognized by anti-farnesyl antibody and is a substrate for farnesyl transferase (FTase) in vitro and that inactivation of FTase increases the amount of unmodified Chs4p in yeast cells. We demonstrate that abolition of Chs4p prenylation causes a ∼60% decrease in CSIII activity, which is correlated with a ∼30% decrease in chitin content and with increased resistance to the chitin binding compound calcofluor white. Furthermore, we show that lack of Chs4p prenylation decreases the average chain length of the chitin polymer. Prenylation of Chs4p, however, is not a factor that mediates plasma membrane association of the protein. Our results provide evidence that the prenyl moiety attached to Chs4p is a factor modulating the activity of CSIII both in vivo and in vitro.

A single Saccharomyces cerevisiae upstream activation site (UAS1) has two distinct regions essential for its activity

1986 ◽  
Vol 6 (12) ◽  
pp. 4690-4696
Author(s):  
B Lalonde ◽  
B Arcangioli ◽  
L Guarente
Keyword(s):  
Saccharomyces Cerevisiae ◽  
Gene Mutations ◽  
Site Directed Mutagenesis ◽  
Single Base ◽  
Protein Factor ◽  
Fold Reduction ◽  
Dependent Protein ◽  
Substitution Mutations ◽  
Activation Site

Several site-directed mutagenesis regimens were used to generate single- and multiple-base substitutions in the upstream activation site UAS1 of the Saccharomyces cerevisiae CYC1 gene. Mutations resulting in large reductions in activity of the site lie in two distinct regions. Six single-base changes in a region A, between -288 and -285, all resulted in a 15-fold reduction in activity. Synthetic sites built up solely of multimers of the -289 to -285 sequence ACCGA behaved as carbon catabolite-sensitive UASs. In addition, substitution mutations in a second region, at nucleotides -266 and -265, virtually eliminated UAS1 activity. These mutations abolished the binding of a heme-dependent protein factor in vitro. Thus, UAS1 contains two essential regions both of which are required for its activity.

Adenovirus DNA: Transcription During Productive Infection, Integration in Transformed Cells, and Replication in Vitro

1975 ◽  
pp. 217-236
Author(s):  
Maurice Green ◽  
Tadashi Yamashita ◽  
Werner Büttner ◽  
Kei Fujinaga ◽  
Max Arens ◽  
...  
Keyword(s):  
Productive Infection ◽  
Transformed Cells ◽  
Dna Transcription

Synthetic octapeptide pyroGLU-ASP-ASP-SER-ASP-GLU-GLU-ASN controls DNA transcription in vitro by RNA polymerase II

1993 ◽  
Vol 49 (10) ◽  
pp. 902-905 ◽  
Author(s):  
A. Angiolillo ◽  
A. Desgro ◽  
V. Marsili ◽  
F. Panara ◽  
G. L. Gianfranceschi
Keyword(s):  
Rna Polymerase ◽  
Rna Polymerase Ii ◽  
Dna Transcription ◽  
Transcription In Vitro

ADP ribosylation factor is an essential protein in Saccharomyces cerevisiae and is encoded by two genes

1990 ◽  
Vol 10 (12) ◽  
pp. 6690-6699
Author(s):  
T Stearns ◽  
R A Kahn ◽  
D Botstein ◽  
M A Hoyt
Keyword(s):  
Saccharomyces Cerevisiae ◽  
Cold Sensitivity ◽  
Animal Cells ◽  
Gene Encoding ◽  
Phenotypic Differences ◽  
Adp Ribosylation ◽  
Protein Factor ◽  
Adp Ribosylation Factor ◽  
Sublethal Concentrations

ADP ribosylation factor (ARF) is a ubiquitous 21-kDa GTP-binding protein in eucaryotes. ARF was first identified in animal cells as the protein factor required for the efficient ADP-ribosylation of the mammalian G protein Gs by cholera toxin in vitro. A gene (ARF1) encoding a protein homologous to mammalian ARF was recently cloned from Saccharomyces cerevisiae (Sewell and Kahn, Proc. Natl. Acad. Sci. USA, 85:4620-4624, 1988). We have found a second gene encoding ARF in S. cerevisiae, ARF2. The two ARF genes are within 28 centimorgans of each other on chromosome IV, and the proteins encoded by them are 96% identical. Disruption of ARF1 causes slow growth, cold sensitivity, and sensitivity to normally sublethal concentrations of fluoride ion in the medium. Disruption of ARF2 causes no detectable phenotype. Disruption of both genes is lethal; thus, ARF is essential for mitotic growth. The ARF1 and ARF2 proteins are functionally homologous, and the phenotypic differences between mutations in the two genes can be accounted for by the level of expression; ARF1 produces approximately 90% of total ARF. Among revertants of the fluoride sensitivity of an arf1 null mutation were ARF1-ARF2 fusion genes created by a gene conversion event in which the deleted ARF1 sequences were repaired by recombination with ARF2.

scholarly journals Assembly of ER-associated protein degradation in vitro: dependence on cytosol, calnexin, and ATP.

1996 ◽  
Vol 132 (3) ◽  
pp. 291-298 ◽  
Author(s):  
A A McCracken ◽  
J L Brodsky
Keyword(s):  
Protein Degradation ◽  
Atp Hydrolysis ◽  
Genetically Engineered ◽  
Heat Inactivation ◽  
Protein Factor ◽  
Transport Vesicles ◽  
Alpha Factor ◽  
Processed Form

To investigate the mechanisms of ER-associated protein degradation (ERAD), this process was reconstituted in vitro. Established procedures for post-translational translocation of radiolabeled prepro-alpha factor into isolated yeast microsomes were modified to inhibit glycosylation and to include a posttranslocation "chase" incubation period to monitor degradation. Glycosylation was inhibited with a glyco-acceptor peptide to compete for core carbohydrates, or by using a radio-labeled alpha factor precursor that had been genetically engineered to eliminate all three glycosylation sites. Inhibition of glycosylation led to the production of unglycosylated pro-alpha factor (p alpha F), a processed form of the alpha factor precursor shown to be a substrate of ERAD in vivo. With this system, both glycosylated and unglycosylated forms of pro-alpha factor were stable throughout a 90-min chase incubation. However, the addition of cytosol to the chase incubation reaction induced a selective and rapid degradation of p alpha F. These results directly reflect the behavior of alpha factor precursor in vivo; i.e., p alpha F is a substrate for ERAD, while glycosylated pro-alpha factor is not. Heat inactivation and trypsin treatment of cytosol, as well as addition of ATP gamma S to the chase incubations, led to a stabilization of p alpha F. ERAD was observed in sec12 microsomes, indicating that export of p alpha F via transport vesicles was not required. Furthermore, p alpha F but not glycosylated pro-alpha factor was found in the supernatant of the chase incubation reactions, suggesting a specific transport system for this ERAD substrate. Finally, the degradation of p alpha F was inhibited when microsomes from a yeast strain containing a disrupted calnexin gene were examined. Together, these results indicate that cytosolic protein factor(s), ATP hydrolysis, and calnexin are required for ER-associated protein degradation in yeast, and suggest the cytosol as the site for degradation.

Protein factor which induces conversion between Physarum ornithine decarboxylase forms in vitro

1981 ◽  
Vol 657 (1) ◽  
pp. 257-267 ◽  
Author(s):  
John L.A. Mitchell ◽  
Tom A. Augustine ◽  
J.Michalel Wilson
Keyword(s):  
Ornithine Decarboxylase ◽  
Protein Factor
Sign in / Sign up

Export Citation Format

Share Document